Clinical trial
Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule: a Multi-centre Study
NCT05693116 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule: a Multi-centre Study
- Lead sponsor
- Istituto Clinico Humanitas
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 1, 2022
- Completion date
- December 31, 2029
- Enrollment
- 300 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
nasal vestibule, nasal vestibule carcinoma, rhinectomy, squamous cell carcinoma